Welcome to our dedicated page for Veeva Sys news (Ticker: VEEV), a resource for investors and traders seeking the latest updates and insights on Veeva Sys stock.
Veeva Systems Inc. reports developments in cloud software, data, AI, and consulting for the life sciences industry. Company news commonly covers adoption of the Veeva Vault Platform, including Development Cloud, Quality Cloud, Commercial Cloud, Data Cloud, Vault CRM, and Veeva MedTech applications for clinical, regulatory, quality, commercial, and medical operations.
Updates also include customer standardization projects with pharmaceutical, biotechnology, medical device, and diagnostics companies; product and data offerings such as Link Key People and Veeva AI; fiscal results and subscription revenue trends; and corporate actions such as acquisitions, including the completed purchase of Ostro as a life sciences brand engagement platform.
Veeva Systems (NYSE: VEEV) will release fiscal 2027 first quarter results, for the period ending April 30, 2026, after market close on June 3, 2026.
The company will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET), with prepared remarks posted on its investor relations site beforehand and a replay available afterward.
Veeva Systems (NYSE: VEEV) announced that medical technology company Smith+Nephew is standardizing its global quality management on Veeva Quality Cloud.
Smith+Nephew will use Veeva QualityDocs, Veeva QMS, and Veeva Training to unify processes, manage quality content, and support over 500,000 annual trainings for compliance and operational efficiency.
Veeva Systems (NYSE:VEEV) will be added to the S&P 500 and will replace Coterra Energy (NYSE:CTRA) effective before the opening of trading on May 7, 2026. Devon Energy (NYSE:DVN) is acquiring Coterra in a transaction expected to close soon, pending final closing conditions.
Veeva (NYSE: VEEV) announced on March 10, 2026 the acquisition of Ostro, a brand engagement platform for life sciences, for approximately $100 million in cash plus long-term equity retention grants. Ostro will operate as an independent unit led by CEO Chase Feiger and will integrate over time with Veeva Commercial Cloud.
Ostro provides AI-driven, MLR-approved conversational responses and engagement analytics to help patients and doctors get compliant answers in real time.
AOP Health is standardizing on Veeva Industry Cloud for Life Sciences (NYSE: VEEV) across development, quality, commercial, and data functions to connect R&D, quality, commercial, and data on a single Vault platform. The move aims to streamline operations, eliminate silos, strengthen quality and safety, and accelerate global growth and time-to-patient.
The collaboration covers Veeva Development Cloud, Quality Cloud, Commercial Cloud, and Data Cloud and is positioned to enable closer cross-team collaboration across sales, marketing, medical, clinical, regulatory, and safety.
Veeva (NYSE: VEEV) reported fiscal 2026 total revenues of $3,195.3M, up 16% year‑over‑year, and Q4 revenues of $836.0M, up 16%.
Operating income rose to $916.4M for the year (up 33%) and fiscal year net income reached $908.9M (up 27%). The company provided FY27 non‑GAAP guidance and said it is advancing industry AI and customer adoption.
Veeva (NYSE: VEEV) announced that more than 125 customers are live on Vault CRM across the U.S., Europe and Japan, including multiple top‑20 biopharma companies. With the availability of Veeva AI, Veeva says it is accelerating the industry's shift to agentic CRM.
Veeva updated the end‑of‑support date for legacy Veeva CRM from September 2030 to end of December 2029. Vault CRM is part of the Vault CRM Suite, which also includes Events Management, Service Center, Campaign Manager, and Patient CRM.
Veeva Systems (NYSE: VEEV) will release fiscal 2026 fourth quarter and full year results for the period ended January 31, 2026, after market close on March 4, 2026.
The company will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) on March 4; prepared remarks are expected at 1:05 p.m. PT (4:05 p.m. ET), and a replay will be available on the investor website.
Veeva Systems (NYSE: VEEV) announced that 13 of the top 20 biopharmas have standardized globally on Veeva Link Key People to enhance customer engagement and supply structured datasets for AI. The product added 38 new customers, and 3 top-20 biopharmas became global standards in the past year.
Link Key People is part of Veeva Data Cloud and uses Veeva's Common Data Architecture to connect Link with OpenData, HCP 360, Compass, AI-powered summaries, personalized notifications, and a high-speed Link Direct Data API for analytics and model feeding.
Veeva (NYSE: VEEV) announced Veeva eSource, a new SiteVault application to eliminate paper at clinical sites and streamline data flow from EHR to EDC. The solution offers direct trial data capture, EHR integration, bidirectional EDC integration, an open API, and aims to remove source data verification work. Early adopter availability is planned for second half of 2026 and requires SiteVault CTMS at the site.